What is Medikabazaar?
Medikabazaar serves as a comprehensive B2B platform for medical procurement, effectively acting as a one-stop destination for hospitals, nursing homes, and clinics. Owned by Boston Ivy Healthcare Solutions Pvt. Ltd., the company addresses the critical need for transparency and reliability in the medical supply chain. Beyond simple product distribution, the platform provides value-added services including medical product consultation, post-sales support, and seamless logistics management. By integrating technology into the procurement process, Medikabazaar has established itself as a vital link in the healthcare ecosystem, enabling medical establishments to optimize their operational workflows and focus on patient care.
How much funding has Medikabazaar raised?
Medikabazaar has raised a total of $445M across 4 funding rounds:
Series A
$5M
Series B
$300M
Series C
$75M
Other Financing Round
$65M
Series A (2018): $5M with participation from HealthQuad and KOIS
Series B (2020): $300M led by Ackermans & Van Haaren
Series C (2021): $75M supported by Ackermans & Van Haaren, Sumitomo Mitsui Financial Group, CDC Group, and KOIS
Other Financing Round (2022): $65M featuring HealthQuad, British International Investment, KOIS Holdings, Creaegis, Ackermans & Van Haaren, and Lighthouse India Fund
Key Investors in Medikabazaar
Ackermans & Van Haaren
A Belgian holding company established in 1876, active in five core industries including marine engineering, private banking, and growth capital.
HealthQuad
India's leading healthcare innovation fund focused on nurturing models that transform healthcare delivery and improve clinical outcomes.
KOIS
A private equity investor specializing in blended finance instruments to scale sustainable solutions across healthcare, education, and climate sectors.
What's next for Medikabazaar?
With the recent strategic investment, Medikabazaar is well-positioned to deepen its market penetration and expand its service offerings. The company is expected to focus on enhancing its digital procurement platform, potentially integrating advanced analytics to predict supply needs and optimize inventory management for its diverse client base. Furthermore, the continued support from global institutional investors suggests a long-term commitment to scaling the platform's reach, potentially exploring new geographic markets or diversifying into specialized medical equipment segments. As the healthcare sector continues to prioritize digital transformation, Medikabazaar remains a key player in driving efficiency and accessibility in medical supply chain management.
See full Medikabazaar company page
